Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses | Patent Publication Number 20200392242
US 20200392242 A1Publication DateDec 17, 2020
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsXiangyang Liu
Jordan Schecter
Jordan Schecter
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.